Literature DB >> 5416827

Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinuses.

Y Sato, M Morita, H O Takahashi, N Watanabe, I Kirikae.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5416827     DOI: 10.1002/1097-0142(197003)25:3<571::aid-cncr2820250312>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

Review 1.  Sphenoid masses in children: radiologic differential diagnosis with pathologic correlation.

Authors:  Y W Lui; S B Dasari; R J Young
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-01       Impact factor: 3.825

2.  Posterior segment toxicity after gemcitabine and docetaxel chemotherapy.

Authors:  Ali Kord Valeshabad; William F Mieler; Vikram Setlur; Merina Thomas; Mahnaz Shahidi
Journal:  Optom Vis Sci       Date:  2015-05       Impact factor: 1.973

3.  Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse
Journal:  Trans Am Ophthalmol Soc       Date:  2005

4.  Prognostic Factors in Paranasal Sinus Squamous Cell Carcinoma and Adenocarcinoma: A SEER Database Analysis.

Authors:  Sumit Jain; Yan Li; Edward C Kuan; Bobby A Tajudeen; Pete S Batra
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-24

5.  Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.

Authors:  R B Raffa; R J Tallarida
Journal:  J Clin Pharm Ther       Date:  2010-06       Impact factor: 2.512

6.  Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases.

Authors:  D Passali; B D Capua; A D Lauretis; E Tucci; R Petrioli; L Bellussi; G Franci
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1999-01

7.  Factors Contributing to Diagnosis and Prognosis in Sinonasal Malignancies.

Authors:  Wenjing Li; Jianqiang You; Haixiang Xue; Changjiang Chao
Journal:  J Immunol Res       Date:  2022-09-29       Impact factor: 4.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.